Free shipping on all orders over $ 500


Cat. No. M1767
R-406 Structure

R406 free base

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 120  USD120 In stock
1mg USD 50  USD50 In stock
5mg USD 120  USD120 In stock
10mg USD 170  USD170 In stock
50mg USD 540  USD540 In stock
100mg USD 780  USD780 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >99%
  • COA
  • MSDS
Biological Activity

R406 is an orally bioavailable and selective inhibitor of spleen tyrosine kinase (Syk) with the IC50 of 41nM and Ki value of 30 nM. R406 is an active component of its prodrug R788 or R935788 (Fostamatinib).

Product Citations
Customer Product Validations & Biological Datas
Source Molecular Medicine Reports (2018). Figure 5. R406 (Abmole Bioscience)
Method HBZY - 1 cell model establishment
Cell Lines HBZY - 1 cell
Concentrations 1.5 µg/ml
Incubation Time 48 h
Results The inhibitor R406 inhibited the LPS-induced activation of the Syk/Ras/c-Fos signaling pathway.
Source Molecular Medicine Reports (2018). Figure 4. R406 (Abmole Bioscience)
Method HBZY - 1 cell model establishment
Cell Lines HBZY - 1 cell
Concentrations 1.5 µg/ml
Incubation Time 48 h
Results Furthermore, R406 was revealed to inhibit the LPS-induced activation of the Syk/Ras/c-Fos signaling pathway.
Cell Experiment
Cell lines CLL cells
Preparation method To evaluate the effect of BCR stimulation on CLL cell viability, CLL cells (107/mL) were incubated in complete RPMI medium (control) or in complete medium supplemented with 10 μg/mL anti-IgM (polyclonal goat F(ab′)2 fragments to human IgM [MP Biomedicals] at 37°C in 5% CO2). After 24 and 48 hours, CLL cell viability was measured by analysis of mitochondrial transmembrane potential by 3,3 dihexyloxocarbocyanine iodine (DiOC6; Invitrogen-Molecular Probes) and cell membrane permeability to propidium iodide (PI; Molecular Probes), as described.13 Briefly, 200 μL cell suspension was collected at the indicated time points and transferred to fluorescence-activated cell sorter tubes containing 200 μL of 60 nM DiOC6 and 2 μg/mL PI in RPMI with 0.5% bovine serum albumin. Cells were then incubated at 37°C for 15 minutes and analyzed within 30 minutes by flow cytometry on a FACSCalibur (BD Biosciences).
Concentrations 5 μM
Incubation time 24 and 48 h
Animal Experiment
Animal models K/BxN Model in C57BL/6 mice
Formulation 35% TPGS, 60% PEG 400, and 5% propylene glycol
Dosages b.i.d for 13 days
Administration orally
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 470.45
Formula C22H23FN6O5
CAS Number 841290-80-0
Purity >99%
Solubility DMSO 11 mg/mL
Storage at -20°C

[1] Quiroga MP, et al. Blood. B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.

[2] Bajpai M. IDrugs. Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseases.

[3] Braselmann S, et al. J Pharmacol Exp Ther. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.

Related Syk Products

GSK2646264 is a potent and selective splenic tyrosine kinase (Syk) inhibitor with a pIC50 value of 7.1. GSK2646264 also inhibited other kinases, with pIC50 values of 5.4, 5.4, 5.3, 5, 4.5, <4.6 and <4.3 for LCK, LRRK2, GSK3β, JAK2, VEGFR2, Aurora B and Aurora A, respectively. GSK2646264 penetrates into the epidermis and dermis of the skin.

GS-9876 (lanraplenib)

Lanraplenib (GS-9876, GS-SYK) is a potent, highly selective and orally active inhibitor of Spleen Tyrosine Kinase (SYK) with IC50 of 9.5 nM. Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans.


SRX3207 is an orally active dual inhibitor of Syk-PI3K with IC50 of 39.9 nM, 31200 nM, 3070 nM, 3070 nM, 244 nM, 388 nM, 9790 nM for Syk, Zap70, BRD41, BRD42, PI3K alpha, PI3K delta, PI3K gamma, respectively. SRX3207 blocks tumor immunosuppression and increases anti-tumor immunity.


RO9021 potently inhibits SYK kinase activity with an average IC50 of 5.6 nM and suppresses B-cell receptor signaling.


WAY-321341 is a syk inhibitor

Abmole Inhibitor Catalog

Keywords: R-406, R406 free base supplier, Syk, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.